Hypopigmented Mycosis Fungoides in Type V Skin: A Report of 5 Cases
Case Reports in Dermatological Medicine · 2011
DOI: 10.1155/2011/190572 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Dermatological Medicine, 2011. Verfasst von Ranthilaka R Ranawaka und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Teaching Hospital Anuradhapura, Anuradhapura, Sri Lanka. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Five patients with type V skin were studied to describe the clinical manifestations, pathological features, and treatment response in hypopigmented mycosis fungoides (HMF). The mean age of patients was 22.4 years at diagnosis, with a mean of 36 months of diagnostic delay. Two were children aged 11 and 13 years. Skin patches were limited to sunlight-covered body areas. In tropical climate, exposure to natural sunlight possibly cured the lesions on sun-exposed areas at early stage of onset. HMF may frequently be misinterpreted as eczema, vitiligo, or progressive macular hypomelanosis clinically and histopathologically as seen in our case series.
Autor:innen und Institutionen
- Department of Dermatology, Teaching Hospital Anuradhapura, Anuradhapura, Sri Lanka.
Zitieren
APA
Ranawaka, R. R., Abeygunasekara, P. H., & de Silva, M. V. (2011). Hypopigmented Mycosis Fungoides in Type V Skin: A Report of 5 Cases. Case Reports in Dermatological Medicine. https://doi.org/10.1155/2011/190572
Vancouver
Ranawaka RR, Abeygunasekara PH, de Silva MV. Hypopigmented Mycosis Fungoides in Type V Skin: A Report of 5 Cases. Case Reports in Dermatological Medicine. 2011. doi:10.1155/2011/190572
BibTeX
@article{Ranawaka2011,
author = {Ranawaka, Ranthilaka R and Abeygunasekara, Priyanka H and de Silva, M V Chandu},
title = {Hypopigmented Mycosis Fungoides in Type V Skin: A Report of 5 Cases},
journal = {Case Reports in Dermatological Medicine},
year = {2011},
doi = {10.1155/2011/190572}
}
EUVIMED